Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

被引:177
作者
Banks, RE [1 ]
Stanley, AJ
Cairns, DA
Barrett, JH
Clarke, P
Thompson, D
Selby, PJ
机构
[1] St James Univ Hosp, Ctr Clin, Canc Res UK, Leeds LS9 7TF, W Yorkshire, England
[2] Leeds Gen Infirm, Dept Clin Biochem & Immunol, Leeds, W Yorkshire, England
关键词
D O I
10.1373/clinchem.2005.051417
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Profiling approaches in proteomics, such as surface-enhanced laser desorption/ionization (SELDI) mass spectrometry, are used in disease marker discovery. The aim of this study was to investigate the potential influence of selected preanalytical factors on the results obtained. Methods: Plasma samples anticoagulated with EDTA, citrate, or heparin, and serum samples from healthy volunteers were profiled by SELDI on CM10, immobilized metal affinity capture (IMAC) array with copper, and H50 chip surfaces. Using linear mixed-effects models, we examined the influence of elapsed time between venipuncture and sample separation (immediate to 24 h) and the type of serum tube used (Greiner Vacuette activator, gel serum separator, or plain tubes). We analyzed purified platelets, as well as platelet-poor and platelet-rich plasma samples treated with calcium and/or thrombin to determine the platelet contribution, directly or via the clotting process, to the profiles generated. We then used cluster analysis to identify samples with similar peak profiles. Results: Different plasma types and sera could be distinguished on the basis of cluster analyses of their spectral profiles. Elapsed time between venipuncture and separation of plasma and serum from blood samples altered the profiles obtained, particularly for serum samples and particularly on IMAC chips. The type of serum collection tube also affected the profiles because of differences in clotting time. In vitro manipulation of platelets revealed that specific peaks in IMAC profiles of serum appeared to be derived directly from platelets. Several other peaks, including some of those exhibiting time-dependent changes, arose during the clotting process. Conclusion: Preanalytical variables, such as sample handling, can markedly influence results. (C) 2005 American Association for Clinical Chemistry.
引用
收藏
页码:1637 / 1649
页数:13
相关论文
共 50 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
ADEYEMI EO, 1988, J CLIN LAB IMMUNOL, V27, P1
[3]   The human plasma proteome - A nonredundant list developed by combination of four separate sources [J].
Anderson, NL ;
Polanski, M ;
Pieper, R ;
Gatlin, T ;
Tirumalai, RS ;
Conrads, TP ;
Veenstra, TD ;
Adkins, JN ;
Pounds, JG ;
Fagan, R ;
Lobley, A .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :311-326
[4]  
[Anonymous], 2003, SAMPLES PATIENT LAB
[5]   Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [J].
Baggerly, KA ;
Morris, JS ;
Coombes, KR .
BIOINFORMATICS, 2004, 20 (05) :777-U710
[6]   Proteomics: new perspectives, new biomedical opportunities [J].
Banks, RE ;
Dunn, MJ ;
Hochstrasser, DF ;
Sanchez, JC ;
Blackstock, W ;
Pappin, DJ ;
Selby, PJ .
LANCET, 2000, 356 (9243) :1749-1756
[7]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[8]  
Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
[9]  
Conrads Thomas P, 2004, Mol Diagn, V8, P77, DOI 10.2165/00066982-200408020-00001
[10]   High-resolution serum proteomic features for ovarian cancer detection [J].
Conrads, TP ;
Fusaro, VA ;
Ross, S ;
Johann, D ;
Rajapakse, V ;
Hitt, BA ;
Steinberg, SM ;
Kohn, EC ;
Fishman, DA ;
Whiteley, G ;
Barrett, JC ;
Liotta, LA ;
Petricoin, EF ;
Veenstra, TD .
ENDOCRINE-RELATED CANCER, 2004, 11 (02) :163-178